Top Markets
Coin of the day
Anthera Pharmaceuticals, Inc. Anthera Pharmaceuticals, Inc.

Anthera Pharmaceuticals, Inc.

ANTH
Rangering i aksjer #42276
Anthera Pharmaceuticals, Inc., a biopharmaceutical enterprise, concentrates on... Anthera Pharmaceuticals, Inc., a biopharmaceutical enterprise, concentrates on developing and commercializing therapeutic solutions for conditions with significant unmet medical needs. The company's pipeline includes Sollpura, an investigational non-porcine pancreatic enzyme replacement therapy in Phase III clinical trials for individuals with exocrine pancreatic insufficiency. It is also advancing Blisibimod, currently in Phase II clinical evaluation for B-cell mediated autoimmune diseases, such as immunoglobulin A nephropathy (IgA nephropathy). Anthera holds licensing agreements with Amgen, Inc. and Eli Lilly and Company. Founded in 2004, the company's base of operations is in Houston, Texas.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-11
Markedsverdi
$2.62K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Anthera Pharmaceuticals, Inc. (ANTH)

Kategori

Historikk for aksjesplitt for Anthera Pharmaceuticals, Inc. (ANTH)
Aksjen Anthera Pharmaceuticals, Inc. (symbol: ANTH) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 13, 2026.
Én ANTH-aksje kjøpt før Aug 13, 2026 tilsvarer i dag 0 ANTH-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR